In 2024, the U.S. Drug Enforcement Administration (DEA) indicated that they plan to reclassify cannabis as being a Timetable III drug. This rescheduling will identify that cannabis has legitimate clinical applications and might help open the doorway to exploration on other likely cure takes adva